WHO-GMP Certified Commercial Pack · Product Code: AKP-077
Xylometazoline Hydrochloride 0.1% w/v Nasal Spray
Formulation Overview: Adult-strength rapid intranasal decongestant spray shrinking engorged nasal turbinate arterioles to facilitate sinus drainage and restorative sleep. Formulated with Xylometazoline Hydrochloride IP 0.1% w/v (0.1% w/v) in Adult Decongestant Nasal Spray dosage form under Respiratory & Allergy, manufactured to IP / BP / USP Compendial standards and supplied in 10 ml Metered-Dose Spray Bottle with Fine-Mist Pump with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-077 |
|---|---|
| Therapeutic Sector | Respiratory & Allergy |
| Dosage Form | Adult Decongestant Nasal Spray |
| Active Ingredient | Xylometazoline Hydrochloride IP 0.1% w/v |
| Strength / Purity | 0.1% w/v |
| Clinical Indication | Acute nasal congestion in adults caused by viral coryza, acute sinusitis, and allergic rhinitis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 ml Metered-Dose Spray Bottle with Fine-Mist Pump |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |